---
sidebar_position: 17
---

# æ–‡ç» 17ï¼šLeveraging Open-Source Large Language Models to Identify Undiagnosed Patients with Rare Genetic Aortopathies

**English Title**: Leveraging Open-Source Large Language Models to Identify Undiagnosed Patients with Rare Genetic Aortopathies

**ä¸­æ–‡æ¨™é¡Œ**: åˆ©ç”¨é–‹æºå¤§å‹èªè¨€æ¨¡å‹è­˜åˆ¥æœªç¢ºè¨ºçš„ç½•è¦‹éºå‚³æ€§ä¸»å‹•è„ˆç–¾ç—…æ‚£è€…
**PMID**: 40950432
**æœŸåˆŠ**: medRxiv
**è©•åˆ†**: 8
**æ‡‰ç”¨é ˜åŸŸ**: é–€è¨º
**DOI**: https://doi.org/10.1101/2025.09.05.25333227

---

## ğŸ“Œ ç¬¬ä¸€å¼µï¼šæ ¸å¿ƒè§€é»å¡

### ä¸»è¦ç™¼ç¾
ç½•è¦‹ç–¾ç—…çš„AIè‡ªå‹•ç¯©æª¢

### æ–‡ç»æ‘˜è¦ï¼ˆAbstractï¼‰
Rare genetic aortopathies are frequently undiagnosed due to phenotypic heterogeneity, and delayed diagnosis can lead to fatal cardiac outcomes. While genetic testing can enable early proactive interventions, it relies on primary care physicians to recognize a genetic basis for symptoms and then refer patients to clinical genetics. Broad-scale screening methods are needed to identify cases that do not fit an obvious diagnostic pattern. Clinical notes, rich in narrative details, may support the automated flagging of patients for genetic testing. Given the strength of Large Language Models (LLMs) in processing unstructured text, we developed an open-source LLM-enabled genetic testing recommendation pipeline, which leverages retrieval augmented generation (RAG) on curated genetic aortopathy-related corpora to utilize relevant clinical knowledge for identifying patients likely to benefit from genetic testing. The pipeline was validated using 22,510 patient progress notes from 500 individuals (250 cases, 250 controls) in the Penn Medicine BioBank, and successfully categorized 425 out of 499 patients, with one case requiring further clinician evaluation due to incomplete information. The pipeline achieved a patient-level recommendation accuracy of 0.852, precision of 0.889, sensitivity of 0.803, F1-score of 0.844, and F3-score of 0.811. Our LLM-enabled workflow that integrates RAG showed strong performance in recommending genetic testing for patients with rare genetic aortopathies, demonstrating its potential to support undiagnosed patient identification from free-text clinical notes, thereby automating early disease identification and improving patient outcomes.

### ä¸­æ–‡æ‘˜è¦
ç½•è¦‹éºå‚³æ€§ä¸»å‹•è„ˆç–¾ç—…ç”±æ–¼è¡¨å‹ç•°è³ªæ€§è€Œç¶“å¸¸æœªè¢«è¨ºæ–·ï¼Œå»¶é²è¨ºæ–·å¯èƒ½å°è‡´è‡´å‘½çš„å¿ƒè‡Ÿçµæœã€‚é›–ç„¶åŸºå› æª¢æ¸¬å¯ä»¥å¯¦ç¾æ—©æœŸä¸»å‹•å¹²é ï¼Œä½†å®ƒä¾è³´æ–¼åˆç´šä¿å¥é†«å¸«è­˜åˆ¥ç—‡ç‹€çš„éºå‚³åŸºç¤ï¼Œç„¶å¾Œå°‡æ‚£è€…è½‰è¨ºè‡³è‡¨åºŠéºå‚³å­¸ã€‚éœ€è¦å¤§è¦æ¨¡ç¯©æŸ¥æ–¹æ³•ä¾†è­˜åˆ¥ä¸ç¬¦åˆæ˜é¡¯è¨ºæ–·æ¨¡å¼çš„ç—…ä¾‹ã€‚å¯Œå«æ•˜è¿°ç´°ç¯€çš„è‡¨åºŠè¨˜éŒ„å¯èƒ½æ”¯æŒè‡ªå‹•æ¨™è¨˜æ‚£è€…é€²è¡ŒåŸºå› æª¢æ¸¬ã€‚é‘‘æ–¼å¤§å‹èªè¨€æ¨¡å‹ï¼ˆLLMsï¼‰åœ¨è™•ç†éçµæ§‹åŒ–æ–‡æœ¬æ–¹é¢çš„å„ªå‹¢ï¼Œæˆ‘å€‘é–‹ç™¼äº†ä¸€å€‹é–‹æºçš„ LLM é©…å‹•åŸºå› æª¢æ¸¬å»ºè­°ç®¡é“ï¼Œè©²ç®¡é“åˆ©ç”¨æª¢ç´¢å¢å¼·ç”Ÿæˆï¼ˆRAGï¼‰å°ç²¾é¸çš„éºå‚³æ€§ä¸»å‹•è„ˆç–¾ç—…ç›¸é—œèªæ–™åº«ï¼Œä»¥åˆ©ç”¨ç›¸é—œè‡¨åºŠçŸ¥è­˜è­˜åˆ¥å¯èƒ½å—ç›Šæ–¼åŸºå› æª¢æ¸¬çš„æ‚£è€…ã€‚è©²ç®¡é“ä½¿ç”¨è³“å·é†«å­¸ç”Ÿç‰©éŠ€è¡Œä¸­ 500 åå€‹é«”ï¼ˆ250 ä¾‹ç—…ä¾‹ï¼Œ250 ä¾‹å°ç…§ï¼‰çš„ 22,510 ä»½æ‚£è€…é€²åº¦è¨˜éŒ„é€²è¡Œé©—è­‰ï¼ŒæˆåŠŸåˆ†é¡äº† 499 åæ‚£è€…ä¸­çš„ 425 åï¼Œå…¶ä¸­ä¸€ä¾‹ç”±æ–¼ä¿¡æ¯ä¸å®Œæ•´éœ€è¦é€²ä¸€æ­¥çš„è‡¨åºŠé†«å¸«è©•ä¼°ã€‚è©²ç®¡é“å¯¦ç¾äº†æ‚£è€…ç´šåˆ¥å»ºè­°æº–ç¢ºç‡ 0.852ã€ç²¾ç¢ºåº¦ 0.889ã€æ•æ„Ÿåº¦ 0.803ã€F1 åˆ†æ•¸ 0.844 å’Œ F3 åˆ†æ•¸ 0.811ã€‚æˆ‘å€‘æ•´åˆ RAG çš„ LLM é©…å‹•å·¥ä½œæµç¨‹åœ¨ç‚ºç½•è¦‹éºå‚³æ€§ä¸»å‹•è„ˆç–¾ç—…æ‚£è€…æ¨è–¦åŸºå› æª¢æ¸¬æ–¹é¢è¡¨ç¾å‡ºè‰²ï¼Œå±•ç¤ºäº†å…¶å¾è‡ªç”±æ–‡æœ¬è‡¨åºŠè¨˜éŒ„ä¸­æ”¯æŒæœªè¨ºæ–·æ‚£è€…è­˜åˆ¥çš„æ½›åŠ›ï¼Œå¾è€Œè‡ªå‹•åŒ–æ—©æœŸç–¾ç—…è­˜åˆ¥ä¸¦æ”¹å–„æ‚£è€…çµæœã€‚

### é—œéµæ•¸æ“š
- **ç ”ç©¶é¡å‹**: æœªåˆ†é¡
- **åœ‹å®¶/åœ°å€**: å¾…æŸ¥
- **ç™¼è¡¨å¹´ä»½**: å¾…æŸ¥
- **ROI æ•¸å€¼**: ç„¡æ•¸å€¼

### æ ¸å¿ƒå‰µæ–°é»
æœ¬ç ”ç©¶çš„ä¸»è¦å‰µæ–°åœ¨æ–¼ï¼šç½•è¦‹ç–¾ç—…çš„AIè‡ªå‹•ç¯©æª¢

---

## âœï¸ ç¬¬äºŒå¼µï¼šParaphrase å¡

### ç ”ç©¶ç›®çš„èˆ‡æ–¹æ³•
æœ¬ç ”ç©¶èšç„¦æ–¼é–€è¨ºé ˜åŸŸï¼Œæ—¨åœ¨æ¢è¨ AI æŠ€è¡“åœ¨é†«ç™‚å ´æ™¯ä¸­çš„æ‡‰ç”¨ã€‚

### ä¸»è¦è²¢ç»
ç ”ç©¶æå‡ºäº†ç½•è¦‹ç–¾ç—…çš„AIè‡ªå‹•ç¯©æª¢ï¼Œç‚ºè‡¨åºŠå¯¦è¸æä¾›äº†æ–°çš„è§£æ±ºæ–¹æ¡ˆã€‚

### æŠ€è¡“ç‰¹é»
- æ‡‰ç”¨å ´æ™¯ï¼šé–€è¨º
- å‰µæ–°ç¨‹åº¦ï¼šè©•åˆ† 8/10
- æœŸåˆŠå½±éŸ¿ï¼šç™¼è¡¨æ–¼ medRxiv

---

## â“ ç¬¬ä¸‰å¼µï¼šå•ç­”å¡

### Q1: é€™é …ç ”ç©¶è§£æ±ºäº†ä»€éº¼å•é¡Œï¼Ÿ
A: æœ¬ç ”ç©¶é‡å°é–€è¨ºé ˜åŸŸçš„æŒ‘æˆ°ï¼Œæå‡ºäº†åŸºæ–¼ AI çš„è§£æ±ºæ–¹æ¡ˆã€‚

### Q2: æ¡ç”¨äº†ä»€éº¼æŠ€è¡“æ–¹æ³•ï¼Ÿ
A: ç½•è¦‹ç–¾ç—…çš„AIè‡ªå‹•ç¯©æª¢

### Q3: ç ”ç©¶çš„ä¸»è¦æˆæœæ˜¯ä»€éº¼ï¼Ÿ
A: ç ”ç©¶ç²å¾—äº† 8 åˆ†çš„å°ˆå®¶è©•åˆ†ï¼Œè­‰æ˜äº†å…¶åœ¨é–€è¨ºé ˜åŸŸçš„æ‡‰ç”¨åƒ¹å€¼ã€‚

### Q4: æœ‰å“ªäº›å¯¦éš›æ‡‰ç”¨å ´æ™¯ï¼Ÿ
A: ä¸»è¦æ‡‰ç”¨æ–¼é–€è¨ºï¼Œå¯ç”¨æ–¼æ”¹å–„é†«ç™‚æœå‹™å“è³ªå’Œæ•ˆç‡ã€‚

---

## ğŸ¤” ç¬¬å››å¼µï¼šä¾‹å¤–å¡

### æ½›åœ¨é™åˆ¶
1. **ç ”ç©¶ç¯„åœ**: ç ”ç©¶è©•åˆ†ç‚º 8/10ï¼Œå¯èƒ½å­˜åœ¨æ”¹é€²ç©ºé–“
2. **åœ°å€å·®ç•°**: ç ”ç©¶ä¾†è‡ªå¾…æŸ¥ï¼Œå…¶ä»–åœ°å€é©ç”¨æ€§éœ€é©—è­‰
3. **ROI æ•¸æ“š**: ç„¡æ•¸å€¼ï¼Œç¶“æ¿Ÿæ•ˆç›Šè©•ä¼°å¯èƒ½ä¸å®Œæ•´

### éœ€è¦é€²ä¸€æ­¥æ¢è¨çš„å•é¡Œ
1. è©²æŠ€è¡“åœ¨ä¸åŒè¦æ¨¡é†«é™¢çš„é©ç”¨æ€§å¦‚ä½•ï¼Ÿ
2. é•·æœŸä½¿ç”¨çš„æ•ˆæœå’Œç©©å®šæ€§æ˜¯å¦ç¶“éé©—è­‰ï¼Ÿ
3. èˆ‡ç¾æœ‰ç³»çµ±æ•´åˆæ™‚å¯èƒ½é¢è‡¨å“ªäº›æŒ‘æˆ°ï¼Ÿ

### æ‰¹åˆ¤æ€§æ€è€ƒ
- **æŠ€è¡“æˆç†Ÿåº¦**: éœ€è¦è©•ä¼°å¾ç ”ç©¶åˆ°å¯¦éš›éƒ¨ç½²çš„è·é›¢
- **æˆæœ¬æ•ˆç›Š**: ç„¡æ•¸å€¼ï¼Œéœ€è¦æ›´è©³ç´°çš„ç¶“æ¿Ÿåˆ†æ
- **å€«ç†è€ƒé‡**: AI åœ¨é–€è¨ºæ‡‰ç”¨æ™‚çš„å€«ç†å’Œéš±ç§å•é¡Œ
- **å¯æ¨å»£æ€§**: ç ”ç©¶çµæœåœ¨å…¶ä»–é†«ç™‚å ´æ™¯çš„é©ç”¨æ€§

---

## ğŸ“š åƒè€ƒè³‡è¨Š
- **PMID**: [40950432](https://pubmed.ncbi.nlm.nih.gov/40950432/)
- **DOI**: https://doi.org/10.1101/2025.09.05.25333227
- **æœŸåˆŠ**: medRxiv
